0001209191-19-051167.txt : 20190930
0001209191-19-051167.hdr.sgml : 20190930
20190930212609
ACCESSION NUMBER: 0001209191-19-051167
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190926
FILED AS OF DATE: 20190930
DATE AS OF CHANGE: 20190930
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Goldberg Jeff Marc
CENTRAL INDEX KEY: 0001703061
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38137
FILM NUMBER: 191127365
MAIL ADDRESS:
STREET 1: C/O AKCEA THERAPEUTICS
STREET 2: 55 CAMBRIDGE PARKWAY, STE 100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AKCEA THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001662524
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472608175
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 22 BOSTON WHARF RD
STREET 2: 9TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 617-207-0202
MAIL ADDRESS:
STREET 1: 22 BOSTON WHARF RD
STREET 2: 9TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-09-26
1
0001662524
AKCEA THERAPEUTICS, INC.
AKCA
0001703061
Goldberg Jeff Marc
C/O AKCEA THERAPEUTICS, INC.
22 BOSTON WHARF ROAD, 9TH FLOOR
BOSTON
MA
02210
0
1
0
0
Chief Operating Officer
Common Stock
2019-09-26
4
M
0
302250
6.48
A
305560
D
Common Stock
2019-09-26
4
F
0
185122
16.64
D
120438
D
Common Stock
2019-09-26
4
M
0
83952
6.48
A
204390
D
Common Stock
2019-09-26
4
F
0
52973
16.64
D
151417
D
Common Stock
2019-09-26
4
M
0
35230
12.21
A
186647
D
Common Stock
2019-09-26
4
F
0
30016
16.64
D
156631
D
Stock Option (right to buy)
6.48
2019-09-26
4
M
0
302250
0.00
D
2025-12-15
Common Stock
302250
0
D
Stock Option (right to buy)
6.48
2019-09-26
4
M
0
83952
0.00
D
2026-02-16
Common Stock
83952
7633
D
Stock Option (right to buy)
12.21
2019-09-26
4
M
0
35230
0.00
D
2027-06-04
Common Stock
35230
17607
D
The shares vest as follows: 1/4th of the shares vest one year after January 5, 2015;1/48th of the shares vest monthly thereafter over the next three years.
The shares vest as follows: 1/4th of the shares vest one year after January 4, 2016;1/48th of the shares vest monthly thereafter over the next three years.
The shares vest as follows: 1/4th of the shares vest one year after January 3, 2017;1/48th of the shares vest monthly thereafter over the next three years.
/s/ Jeffrey M. Goldberg
2019-09-30